CROS
Private Company
Funding information not available
Overview
CROS CRO is a private, full-service contract research organization headquartered in Warsaw, Poland, operating in the clinical trial services sector. Founded in 2008, it has established itself as a regional player offering expertise across the entire drug development lifecycle, including complex First-in-Human trials. Its business model is service-based, generating revenue by managing and executing clinical trials for biopharmaceutical clients. The company's value proposition lies in its therapeutic focus and operational presence in Central and Eastern Europe, a region known for cost-effective patient recruitment.
Technology Platform
Integrated clinical trial service platform covering all phases (I-IV) and functions, from protocol design and regulatory submissions to monitoring, data management, and pharmacovigilance, with specialized expertise in First-in-Human and early-phase trials.
Opportunities
Risk Factors
Competitive Landscape
CROS operates in the highly fragmented and competitive global CRO market. It competes directly with other regional CROs in Central and Eastern Europe and indirectly with large multinational CROs (e.g., IQVIA, ICON, Parexel) that have global scale and broad service offerings. Its competitive differentiation is based on deep local regulatory expertise, cost advantages, and personalized service for mid-sized and small biotech sponsors.